161.10
0.54%
+0.87
전일 마감가:
$160.23
열려 있는:
$163.55
하루 거래량:
450.85K
시가총액:
$4.59B
수익:
-
순이익/손실:
$10.93M
주가수익비율:
-109.59
EPS:
-1.47
순현금흐름:
$-100.60M
1주 성능:
+2.69%
1개월 성능:
-9.43%
6개월 성능:
+31.89%
1년 성능:
+91.99%
Krystal Biotech Inc Stock (KRYS) Company Profile
명칭
Krystal Biotech Inc
전화
412-586-5830
주소
2100 Wharton Street, Suite 701, Pittsburgh, PA
Krystal Biotech Inc Stock (KRYS) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2023-11-20 | 개시 | Goldman | Buy |
2023-10-24 | 개시 | Cantor Fitzgerald | Overweight |
2023-10-12 | 개시 | Citigroup | Buy |
2023-09-07 | 개시 | Berenberg | Buy |
2023-04-18 | 개시 | Stifel | Buy |
2023-02-28 | 업그레이드 | Goldman | Neutral → Buy |
2022-08-25 | 다운그레이드 | Goldman | Buy → Neutral |
2022-01-18 | 개시 | BofA Securities | Buy |
2021-07-20 | 업그레이드 | Goldman | Neutral → Buy |
2020-09-18 | 개시 | B. Riley FBR | Buy |
2020-06-04 | 개시 | Evercore ISI | Outperform |
2019-09-24 | 개시 | Goldman | Neutral |
2019-08-06 | 재확인 | H.C. Wainwright | Buy |
2019-06-24 | 재확인 | Chardan Capital Markets | Buy |
2019-06-24 | 재확인 | H.C. Wainwright | Buy |
2019-05-30 | 개시 | Guggenheim | Buy |
2018-09-11 | 개시 | Cantor Fitzgerald | Overweight |
모두보기
Krystal Biotech Inc 주식(KRYS)의 최신 뉴스
Why Krystal Biotech (KRYS) Might Surprise This Earnings Season
Zacks Investment Research
Krystal Biotech to Present at the Association for Research in Vision and Ophthalmology 2024 Annual Meeting
GlobeNewswire Inc.
Krystal Biotech to Report First Quarter 2024 Financial Results on May 6, 2024
GlobeNewswire Inc.
Down -7.21% in 4 Weeks, Here's Why Krystal Biotech (KRYS) Looks Ripe for a Turnaround
Zacks Investment Research
Krystal Biotech (KRYS) is on the Move, Here's Why the Trend Could be Sustainable
Zacks Investment Research
Krystal Biotech to Present at the American Association for Cancer Research 2024 Annual Meeting
GlobeNewswire Inc.
Krystal Biotech Inc (KRYS) 재무 분석
Krystal Biotech Inc (KRYS) 순이익 2024
KRYS은 2023-12-31 종료 분기에 대해 순이익(지난 12개월)이 10.93M 달러로 보고했으며, 전년대비 +107.81% 증가했습니다.
Krystal Biotech Inc (KRYS) 현금흐름 2024
2023-12-31 종료 분기에 KRYS은 현금흐름(지난 12개월)으로 -100.60M 달러를 기록했으며, 전년 대비 +34.48% 증가했습니다.
Krystal Biotech Inc (KRYS) 주당 순이익 2024
KRYS이 보고한 2023-12-31 종료 분기의 주당 순이익(지난 12개월)은 0.09달러이며, 전년 대비 +101.63% 성장했습니다.
Krystal Biotech Inc 주식 (KRYS) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Krishnan Krish S | President and CEO |
Mar 11 '24 |
Sale |
170.96 |
25,000 |
4,274,040 |
1,550,882 |
Krishnan Suma | President, R&D |
Mar 11 '24 |
Sale |
170.95 |
25,000 |
4,273,679 |
1,612,262 |
Krishnan Krish S | President and CEO |
Mar 11 '24 |
Sale |
170.95 |
25,000 |
4,273,679 |
1,612,262 |
ROMANO KATHRYN | Chief Accounting Officer |
Feb 28 '24 |
Option Exercise |
63.55 |
7,500 |
476,625 |
14,536 |
ROMANO KATHRYN | Chief Accounting Officer |
Feb 28 '24 |
Option Exercise |
31.77 |
10,000 |
317,750 |
17,936 |
Krishnan Suma | President, R&D |
Feb 28 '24 |
Option Exercise |
0.00 |
12,500 |
0 |
1,643,047 |
Krishnan Suma | President, R&D |
Feb 28 '24 |
Option Exercise |
0.00 |
7,500 |
0 |
1,579,353 |
Krishnan Krish S | President and CEO |
Feb 28 '24 |
Option Exercise |
0.00 |
7,500 |
0 |
1,579,353 |
Krishnan Krish S | President and CEO |
Feb 28 '24 |
Option Exercise |
0.00 |
12,500 |
0 |
1,643,047 |
ROMANO KATHRYN | Chief Accounting Officer |
Feb 28 '24 |
Sale |
166.05 |
7,500 |
1,245,381 |
12,936 |
자본화:
|
볼륨(24시간):